INmune Bio Inc. INMB
1.13 USD 0.00 (+0.00%)
At closeNov 9, 2026, 6:33 PM EST
1.16 +0.03 +2.65%
After hours · Nov 9, 6:33 PM ET
1.08 Day range 1.20
1.06 52-week range 2.60
- YTD
- -27.56%
- 1 year
- -30.67%
News
seekingalpha.com INmune Bio Inc. (INMB) Q3 2026 Earnings Call Prepared Remarks Transcript INmune Bio Inc. ( INMB ) Q3 2026 Earnings Call November 5, 2026 4:30 PM EST Company Participants Daniel Carlson - Head of Investor Relations David Moss - President, CEO, Treasurer, Secretary &…
benzinga.com INmune Bio Q3 2026 Earnings Call Transcript INmune Bio (NASDAQ:INMB) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you…
benzinga.com INmune Bio Q3 EPS $(0.17) Misses $(0.15) Estimate INmune Bio (NASDAQ:INMB) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.15) by 13.33 percent. This is a 29.17 percent increase over losses of…- benzinga.com INmune Bio Submits Final Pre-Marketing Authorization Application Package To UK MHRA For Ebstrocel For Recessive Dystrophic Epidermolysis Bullosa; Expects Full MAA Submission In Early February 2027, With Potential UK Approval In Mid-2027; Has Engaged U.S. Regulatory Advisors With Rare Disease Expertise To Prepare And Submit A Type B Meeting Request To FDA INmune Bio Inc. (NASDAQ:INMB) (the "Company"), a late-stage biotechnology company focused on inflammation and immunology, today announced that it has submitted its final pre-Marketing Authorisation…
benzinga.com INmune Bio And Quantum Computing Inc. Partner To Use Quantum AI To Identify New Treatment Applications For Alzheimer’s Drug XPro Collaboration combines INmune Bio's clinical research with QCi's Dirac-3S quantum optimization machine to identify potential new treatment indications and biomarkers for XProInitial engagement marks…
benzinga.com Full Transcript: INmune Bio Q2 2026 Earnings Call INmune Bio (NASDAQ:INMB) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. Benzinga APIs provide real-time access to earnings call…
benzinga.com INmune Bio Submits Two Regulatory Packages To EMA For Ebstrocel: Application For Orphan Drug Designation And Scientific Advice Package To Streamline Upcoming MAA In Europe Orphan Drug Designation application and pre-MAA Scientific Advice package submitted for Ebstrocel™ in RDEBFilings support a planned EU MAA in Q1 2027; orphan designation, if granted and maintained…
benzinga.com INmune Bio Reaches Manufacturing Milestone with First Commercial-Ready CORDStrom Umbilical Cord Tissue Processed At CGT Catapult In Partnership With Anthony Nolan Cord Blood Bank Commercial-Ready Manufacturing Now Supports Planned Phase 3 Confirmation Trial, and US, EU and UK Regulatory Submissions for Future Commercial Supply.Company Expresses Support for MHRA Draft Rare…- benzinga.com INmune Announces Publication Of Peer-Reviewed Study In The Journal Of Neurotrauma On Traumatic Brain Injury And Alzheimer’s; Treatment With Its Lead Neuroinflammation Candidate XPro1595 Prevented Injury-Induced Rise In Amyloid Pathology The Department of Defense–funded study; entitled: "Inhibition of Soluble TNF Mitigates Traumatic Brain Injury as a Risk Factor for the Development of Amyloidogenic Proteins and Functional Deficits in…
benzinga.com INmune Bio To Present New Imaging Data From Phase 2 Study Of XPro In Patients With Early Alzheimer’s Disease At AAIC Advanced MRI analyses showed early treatment-related changes in white matter myelin integrity and cortical microstructure at Week 24, supporting biologic activity of selective soluble TNF…
benzinga.com Earnings Scheduled For March 30, 2026 
benzinga.com Earnings Scheduled For October 30, 2025 
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session 
benzinga.com Earnings Scheduled For August 7, 2025 - benzinga.com Traders Circulate Business Insider Article Titled "Looking for the short-squeeze candidate? These 5 stocks have potential."; Shares See Volume https://www.businessinsider.com/short-squeeze-stock-market-meme-stocks-retail-investors-25-8
- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com Why Celcuity Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket 
benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session 
benzinga.com Dow Gains Over 100 Points; Chicago PMI Weakens In June - benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com Why Venus Concept Shares Are Trading Higher By Over 32%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session
- benzinga.com Earnings Scheduled For May 8, 2025
benzinga.com Why Calix Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket - benzinga.com Earnings Scheduled For March 27, 2025
benzinga.com C-Suite Buy of the Week: Executive Moves from Biotech to Banking - benzinga.com Earnings Scheduled For March 28, 2024 Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million.
benzinga.com Earnings Scheduled For November 1, 2023 Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1.07 per share on revenue of $9.37 billion.- benzinga.com Earnings Scheduled For August 7, 2023 Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report quarterly loss at $0.44 per share on revenue of $153.69 million.
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For June 1, 2023
- benzinga.com Earnings Scheduled For March 2, 2023 Companies Reporting Before The Bell • argenx (NASDAQ:ARGX) is expected to report quarterly loss at $3.03 per share on revenue of $176.89 million.
- benzinga.com Earnings Scheduled For November 2, 2022 Companies Reporting Before The Bell • Nomura Holdings (NYSE:NMR) is likely to report earnings for its second quarter.
- benzinga.com Earnings Scheduled For August 3, 2022 Companies Reporting Before The Bell • Fresh Del Monte Produce (NYSE:FDP) is likely to report quarterly earnings at $0.79 per share on revenue of $1.15 billion.
- benzinga.com 71 Biggest Movers From Yesterday Gainers CynergisTek, Inc. (NYSE: CTEK) shares surged 100% to close at $1.18 on Tuesday after the company entered into a definitive agreement to be acquired by Clearwater Compliance for roughly $17.7…
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2022 Upgrades
- benzinga.com Earnings Scheduled For May 5, 2022 Companies Reporting Before The Bell • Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday During Tuesday's session, 454 stocks hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 671 companies achieved new lows for the year.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday During Thursday, 166 stocks hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday Tuesday's session saw 729 companies set new 52-week lows.
- benzinga.com Earnings Scheduled For March 3, 2022 Companies Reporting Before The Bell • Travelzoo (NASDAQ:TZOO) is expected to report quarterly earnings at $0.13 per share on revenue of $18.23 million.
- benzinga.com The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight Biopharma stocks lock-stepped with the broader market in the week ending Feb. 25 before finishing higher. The trajectory was the same, with the sector declining in the first two sessions of the…
- benzinga.com Stocks That Hit 52-Week Lows On Friday During Friday's session, 445 companies made new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 615 stocks hit new 52-week lows.
- benzinga.com 92 Biggest Movers From Friday Gainers
- benzinga.com Earnings Scheduled For November 3, 2021 Companies Reporting Before The Bell • R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.
- benzinga.com 46 Stocks Moving In Thursday's Mid-Day Session Gainers Sphere 3D Corp. (NASDAQ: ANY) shares surged 36% to $9.02 as traders circulate a tweet from popular Twitter trader Will Meade saying 'Long $ANY this is the next $SPRT and they have a very good…
- benzinga.com Earnings Scheduled For August 4, 2021 Companies Reporting Before The Bell • UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter.
- benzinga.com Earnings Scheduled For May 5, 2021 Companies Reporting Before The Bell • Monmouth Real Estate (NYSE:MNR) is likely to report earnings for its second quarter.